Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
May 16, 2019 Off

Taro to Announce Full Year Results on May 22, 2019

By BusinessWire

Earnings Call to Discuss Results to be Conducted Thursday, May 23 at 8:00 am ET HAWTHORNE, N.Y.–(BUSINESS WIRE)–Taro Pharmaceutical Industries…

May 16, 2019 Off

Veteran Products Liability Litigator Shevon Rockett Joins Dorsey’s New York Office

By BusinessWire

NEW YORK–(BUSINESS WIRE)–International law firm Dorsey & Whitney LLP is pleased to announce that Shevon Rockett has joined the Firm…

May 16, 2019 Off

Global Lung Cancer Drugs Market Report 2019-2025 – The Pipeline of Oncology Drugs in the Clinical Development has Expanded by 45% Over the Past 10 Years – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Lung Cancer Drugs Market – Drivers, Restraints, Opportunities, Trends, and Forecast up to 2025” report has been…

May 16, 2019 Off

Takeda to Showcase Growing Pipeline and Diversified Portfolio of Oncology Products at Upcoming Scientific Congresses

By BusinessWire

– New Data to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting and the Congress of…

May 16, 2019 Off

meltmedia receives Inc.’s 2019 Best Workplaces Award

By BusinessWire

Agency named as a top U.S. employer TEMPE, Ariz.–(BUSINESS WIRE)–Inc. magazine has selected meltmedia as a winner of its 2019…

May 16, 2019 Off

Quanterix Announces $50,000 in Grants to Support Promising Oncology Research

By BusinessWire

Grants to be awarded to researchers with the most transformative ideas for disrupting precision medicine through biomarker research in Quanterix’…

May 16, 2019 Off

H3 Biomedicine to Present Data from Two Ongoing Precision Medicine Clinical Programs at 2019 ASCO Annual Meeting

By BusinessWire

—Phase 1 dose escalation of H3B-6545, a potential first-in-class Selective ERα Covalent Antagonist (SERCA), in women with ER-positive, HER2-negative breast…

May 16, 2019 Off

InCrowd’s Janet Kosloff Named One of the 2019 PM360 ELITE 100

By BusinessWire

A top influencer among Entrepreneurs in the healthcare industry today WATERTOWN, Mass.–(BUSINESS WIRE)–InCrowd, pioneer of the real-time market intelligence platform…

May 16, 2019 Off

Global Chemotherapy Treatment Market 2019-2023 | Development of Combination Therapies to Boost Growth | Technavio

By BusinessWire

LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Biotechnology?src=hash" target="_blank"gt;#Biotechnologylt;/agt;–The global chemotherapy treatment market is expected to post a CAGR of close to 3% during the…

May 16, 2019 Off

Epizyme Announces New Tazemetostat Clinical Data to be Presented in Oral Sessions at Multiple Upcoming Medical Meetings

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Epizyme, Inc. (Nasdaq: EPZM), a late-stage biopharmaceutical company developing novel epigenetic therapies, today announced that new data from…

Posts pagination

Previous 1 … 3,183 3,184 3,185 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine